• Pilot Indocyanine Green™ Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

  Stanford is currently accepting patients for this trial.

• Pilot Indocyanine Green™ Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple Negative Breast Cancer (IMpassion130)

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

  Stanford is currently accepting patients for this trial.

• Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

  Stanford is currently accepting patients for this trial.

• Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer

  Stanford is currently accepting patients for this trial.

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• National Breast Cancer and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Brief Behavioral Intervention for Insomnia During Chemotherapy

  Stanford is currently accepting patients for this trial.

• A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer

  Stanford is currently accepting patients for this trial.

• Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

  Stanford is currently accepting patients for this trial.

• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

  Stanford is currently accepting patients for this trial.

• 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

  Stanford is currently accepting patients for this trial.

• Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

  Stanford is currently accepting patients for this trial.

• Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy

  Stanford is currently accepting patients for this trial.

• FNA Tumor Sampling for CD137 Modulation: A Pilot Study

  Stanford is currently accepting patients for this trial.

• Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Molecular and Cellular Analysis of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search

No trials match your search

No trials match your search

No trials match your search

No trials match your search

• National Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• National Breast Cancer and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Placebo-controlled Lymphedema Study for Arm or Leg Lymphedema

  Stanford is currently accepting patients for this trial.

No trials match your search

• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma

  Stanford is currently accepting patients for this trial.

• Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

  Stanford is currently accepting patients for this trial.

• Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

  Stanford is currently accepting patients for this trial.

• Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

  Stanford is currently accepting patients for this trial.

• Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

  Stanford is currently accepting patients for this trial.

• Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

  Stanford is currently accepting patients for this trial.

• Study of the Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkins Lymphoma

  Stanford is currently accepting patients for this trial.

• Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors

  Stanford is currently accepting patients for this trial.

• Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

  Stanford is currently accepting patients for this trial.

• Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

  Stanford is currently accepting patients for this trial.

• Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

  Stanford is currently accepting patients for this trial.

• Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group

  Stanford is currently accepting patients for this trial.

• A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa

  Stanford is currently accepting patients for this trial.

• Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

  Stanford is currently accepting patients for this trial.

• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

  Stanford is currently accepting patients for this trial.

• Trial of CMB305 and Atezolizumab in Patients With Sarcoma

  Stanford is currently accepting patients for this trial.

• PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.